<!DOCTYPE html>
<html lang="en" prefix="og: http://ogp.me/ns#">
<head>
	<meta charset="UTF-8">
<meta name="viewport" content="width=device-width">
<title>

Wuhan Data • covid.datahelps.life

</title>
<meta name="description" content=" Derive insights from covid-19 datasets for saving lives">
<link rel="alternate" type="application/rss+xml" title="RSS 2.0" href="/feed.xml">

<!-- icons -->
<link rel="apple-touch-icon" href="/apple-touch-icon.png">
<link rel="icon" type="image/png" href="/favicon-96x96.png" sizes="96x96">
<link rel="icon" type="image/png" href="/favicon-32x32.png" sizes="32x32">
<link rel="icon" type="image/png" href="/android-chrome-192x192.png" sizes="192x192">
<meta name="theme-color" content="#515675">
<meta name="msapplication-TileColor" content="#515675">
<meta name="msapplication-TileImage" content="/mstile-310x310.png">
<!-- /icons -->

<script src="/js/jquery.2.1.4.min.js"></script>
<script src="/js/modernizr.js"></script>
<script src="/js/fitvids.js"></script>
<link href='//fonts.googleapis.com/css?family=Source+Code+Pro:400,700|Source+Sans+Pro:600,900|Crimson+Text:700italic,600,600italic,400,700,400italic' rel='stylesheet' type='text/css'>
<link rel="stylesheet" href="/css/reset.css">
<link rel="stylesheet" href="/css/pygments.css">

<link rel="stylesheet" href="/css/style.css">
<!--[if gte IE 9]>
  <style type="text/css">
    .gradient {
       filter: none;
    }
  </style>
<![endif]-->


<style>
header {
  margin-bottom: 40px;
}
@media all and (min-width: 500px) {
  header {
    margin-bottom: 100px;
  }
}
header::after {
  display: none;
}
</style>


</head>
<body>
	
	<div class="wrap">
		<header>
  <a href="/" class="website-title">
    
      covid.datahelps.life
    
  </a>
  <nav>
  <a href="/about/">About</a>
  <a href="/prediction/">Prediction tools</a>
  <a href="/data/">Data</a>
</nav>

  
  
</header>

		<article>
	<h1>Wuhan Data</h1>
		<p>775 COVID-19 positive patients from Wuhan, China. Most patients were under relatively mild conditions. 
The analytics below show the baseline and univariate analytics of the cohort.</p>

<h3 id="characteristics-of-wuhan-cohort">Characteristics of Wuhan Cohort</h3>
<p><em>Data are median (IQR) or number (%). 
Two patients had missing data for death, three patients had missing data for poor outcome.</em></p>

<table>
  <thead>
    <tr>
      <th>Variable</th>
      <th>N (all)</th>
      <th>All (n=775)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><strong>Demographic</strong></td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>Age</td>
      <td>775</td>
      <td>61 (50-68)</td>
    </tr>
    <tr>
      <td>Sex (male)</td>
      <td>775</td>
      <td>379 (48.9%)</td>
    </tr>
    <tr>
      <td><strong>Outcome</strong></td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>Death</td>
      <td>773</td>
      <td>33 (4.3%)</td>
    </tr>
    <tr>
      <td>Poor outcome</td>
      <td>772</td>
      <td>75 (9.7%)</td>
    </tr>
    <tr>
      <td><strong>Underlying Conditions</strong></td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>Chronic lung disease</td>
      <td>771</td>
      <td>48 (6.2%)</td>
    </tr>
    <tr>
      <td>Diabetes Mellitus</td>
      <td>771</td>
      <td>106 (13.7%)</td>
    </tr>
    <tr>
      <td>Weakened immune system</td>
      <td>771</td>
      <td>12 (1.5%)</td>
    </tr>
    <tr>
      <td>Malignancy</td>
      <td>771</td>
      <td>24 (3.1%)</td>
    </tr>
    <tr>
      <td>Hypertension</td>
      <td>771</td>
      <td>239 (30.8%)</td>
    </tr>
    <tr>
      <td>Heart disease</td>
      <td>771</td>
      <td>85 (11.0%)</td>
    </tr>
    <tr>
      <td>Chronic renal disease</td>
      <td>771</td>
      <td>25 (3.2%)</td>
    </tr>
    <tr>
      <td><strong>Symptoms</strong></td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>fever</td>
      <td>773</td>
      <td>532 (68.6%)</td>
    </tr>
    <tr>
      <td>coughing</td>
      <td>773</td>
      <td>528 (68.1%)</td>
    </tr>
    <tr>
      <td>fatigue</td>
      <td>773</td>
      <td>421 (54.3%)</td>
    </tr>
    <tr>
      <td>dyspnea</td>
      <td>773</td>
      <td>355 (45.8%)</td>
    </tr>
    <tr>
      <td>diarrhea</td>
      <td>773</td>
      <td>36 (4.6%)</td>
    </tr>
    <tr>
      <td><strong>Admission clinical features</strong></td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>CURB-65 Score</td>
      <td>767</td>
      <td>0 (0-1)</td>
    </tr>
    <tr>
      <td>ARDS mild</td>
      <td>764</td>
      <td>1 (0.1%)</td>
    </tr>
    <tr>
      <td>ARDS moderate</td>
      <td>764</td>
      <td>15 (1.9%)</td>
    </tr>
    <tr>
      <td>ARDS severe</td>
      <td>764</td>
      <td>27 (3.5%)</td>
    </tr>
    <tr>
      <td>IgM antibodies (g/L)</td>
      <td>496</td>
      <td>35.6 (12.6-77.0)</td>
    </tr>
    <tr>
      <td>IgG antibodies (g/L)</td>
      <td>498</td>
      <td>153.3 (90.2-183.6)</td>
    </tr>
    <tr>
      <td>Neutrophil count (10^9/L)</td>
      <td>739</td>
      <td>3.5 (2.7-4.9)</td>
    </tr>
    <tr>
      <td>Lymphocyte (10^9/L)</td>
      <td>743</td>
      <td>1.4 (1.1-1.9)</td>
    </tr>
    <tr>
      <td>Platelet (10^9/L)</td>
      <td>732</td>
      <td>224 (180-274)</td>
    </tr>
    <tr>
      <td>C-reactive protein (mg/L)</td>
      <td>684</td>
      <td>2.7 (0.9-14.1)</td>
    </tr>
    <tr>
      <td>D-dimer (mg/L)</td>
      <td>581</td>
      <td>0.4 (0.2-1.1)</td>
    </tr>
    <tr>
      <td>Creatinine (μmol/L)</td>
      <td>728</td>
      <td>63.9 (54.1-76.4)</td>
    </tr>
    <tr>
      <td>Alanine aminotransferase (IU/L)</td>
      <td>723</td>
      <td>22.9 (14.8-39.5)</td>
    </tr>
    <tr>
      <td><strong>Hospital course</strong></td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>Hospitalisation duration</td>
      <td>771</td>
      <td>12 (8-20)</td>
    </tr>
    <tr>
      <td><strong>Interventions</strong></td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>Oxygen therapy</td>
      <td>772</td>
      <td>576 (74.3%)</td>
    </tr>
    <tr>
      <td>Noninvasive positive pressure ventilation</td>
      <td>772</td>
      <td>40 (5.2%)</td>
    </tr>
    <tr>
      <td>High Flow Nasal Cannula</td>
      <td>772</td>
      <td>50 (6.5%)</td>
    </tr>
    <tr>
      <td>Intubation</td>
      <td>772</td>
      <td>21 (2.7%)</td>
    </tr>
    <tr>
      <td>Extracorporeal membrane oxygenation</td>
      <td>772</td>
      <td>2 (0.3%)</td>
    </tr>
    <tr>
      <td>Steroid</td>
      <td>772</td>
      <td>78 (10.1%)</td>
    </tr>
  </tbody>
</table>

<h3 id="univariate-analytics-of-risk-factors">Univariate analytics of risk factors</h3>

<table>
  <thead>
    <tr>
      <th><br /> Variable</th>
      <th>Death<br /> Odds ratio (CI at 95%)</th>
      <th><br /> p-value</th>
      <th>Poor outcome<br /> Odds ratio (CI at 95%)</th>
      <th><br /> p-value</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><strong>Demographic</strong></td>
      <td> </td>
      <td> </td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>Age</td>
      <td>1.06 (1.03-1.10)</td>
      <td>&lt;0.0001</td>
      <td>1.07 (1.04-1.09)</td>
      <td>&lt;0.0001</td>
    </tr>
    <tr>
      <td>Sex (male)</td>
      <td>1.88 (0.91-3.87)</td>
      <td>0.12</td>
      <td>1.54 (0.95-2.50)</td>
      <td>0.099</td>
    </tr>
    <tr>
      <td><strong>Premorbid Conditions</strong></td>
      <td> </td>
      <td> </td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>Chronic lung disease</td>
      <td>5.32 (2.15-13.13)</td>
      <td>0.00029</td>
      <td>6.13 (3.16-11.88)</td>
      <td>&lt;0.0001</td>
    </tr>
    <tr>
      <td>Diabetes Mellitus</td>
      <td>2.38 (1.03-5.49)</td>
      <td>0.069</td>
      <td>1.58 (0.85-2.96)</td>
      <td>0.2</td>
    </tr>
    <tr>
      <td>Weakened immune system</td>
      <td>5.21 (1.09-24.89)</td>
      <td>0.12</td>
      <td>7.35 (2.27-23.78)</td>
      <td>0.00075</td>
    </tr>
    <tr>
      <td>Malignancy</td>
      <td>2.33 (0.52-10.39)</td>
      <td>0.55</td>
      <td>1.99 (0.66-5.99)</td>
      <td>0.37</td>
    </tr>
    <tr>
      <td>Hypertension</td>
      <td>2.68 (1.29-5.58)</td>
      <td>0.012</td>
      <td>3.37 (2.06-5.53)</td>
      <td>&lt;0.0001</td>
    </tr>
    <tr>
      <td>Heart disease</td>
      <td>4.43 (2.00-9.81)</td>
      <td>0.00024</td>
      <td>4.42 (2.51-7.77)</td>
      <td>&lt;0.0001</td>
    </tr>
    <tr>
      <td>Chronic renal disease</td>
      <td>5.26 (1.68-16.42)</td>
      <td>0.008</td>
      <td>4.99 (2.07-12.02)</td>
      <td>0.00032</td>
    </tr>
    <tr>
      <td><strong>Symptoms</strong></td>
      <td> </td>
      <td> </td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>fever</td>
      <td>1.16 (0.53-2.55)</td>
      <td>0.86</td>
      <td>1.08 (0.64-1.82)</td>
      <td>0.88</td>
    </tr>
    <tr>
      <td>coughing</td>
      <td>3.35 (1.16-9.65)</td>
      <td>0.03</td>
      <td>1.49 (0.85-2.59)</td>
      <td>0.2</td>
    </tr>
    <tr>
      <td>fatigue</td>
      <td>1.42 (0.68-2.95)</td>
      <td>0.44</td>
      <td>1.52 (0.93-2.50)</td>
      <td>0.12</td>
    </tr>
    <tr>
      <td>dyspnea</td>
      <td>5.43 (2.21-13.35)</td>
      <td>&lt;0.0001</td>
      <td>3.33 (1.97-5.64)</td>
      <td>&lt;0.0001</td>
    </tr>
    <tr>
      <td>diarrhea</td>
      <td>0.65 (0.09-4.89)</td>
      <td>1</td>
      <td>0.26 (0.03-1.92)</td>
      <td>0.26</td>
    </tr>
    <tr>
      <td><strong>Admission clinical features</strong></td>
      <td> </td>
      <td> </td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>Neutrophil count (10^9/L)</td>
      <td>1.08 (1.02-1.14)</td>
      <td>0.00034</td>
      <td>1.33 (1.22-1.44)</td>
      <td>0.0006</td>
    </tr>
    <tr>
      <td>Lymphocyte (10^9/L)</td>
      <td>0.02 (0.01-0.08)</td>
      <td>0.002</td>
      <td>0.17 (0.10-0.29)</td>
      <td>0.0013</td>
    </tr>
    <tr>
      <td>Platelet (10^9/L)</td>
      <td>0.99 (0.98-1.00)</td>
      <td>0.04</td>
      <td>0.99 (0.99-1.00)</td>
      <td>0.024</td>
    </tr>
    <tr>
      <td>C-reactive protein (mg/L)</td>
      <td>1.03 (1.02-1.04)</td>
      <td>&lt;0.0001</td>
      <td>1.03 (1.02-1.03)</td>
      <td>&lt;0.0001</td>
    </tr>
    <tr>
      <td>Creatinine (μmol/L)</td>
      <td>1.01 (1.00-1.01)</td>
      <td>0.0032</td>
      <td>1.01 (1.01-1.02)</td>
      <td>0.0093</td>
    </tr>
  </tbody>
</table>

</article>

	  <script>
	    $("article").fitVids();
	    $('article p').each(function(i){
				if (($(this).find('img').length) && (!$.trim($(this).text()).length))  {
					$(this).addClass('img-only');
				}
				if ($.trim($(this).text()).length - $.trim($(this).find('small').text()).length == 0 && ($(this).find('img').length)){
					$(this).addClass('img-only-source');
				}
	  	});
	  </script>
	</div>
	
<!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-72059605-2"></script>
<script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());

    gtag('config', 'UA-72059605-2');
</script>
<footer>
  <div class="inner">
    <p>Insights derived from COVID-19 Datasets</p>
  </div>
</footer>

</body>
</html>
